Exelixis to Webcast Fireside Chats as Part of Investor Conferences in September
31 Agosto 2023 - 5:05PM
Business Wire
-- Presentations to be webcast on
www.exelixis.com --
Exelixis, Inc. (Nasdaq: EXEL) today announced that members of
the company’s management team will participate in fireside chats at
the following investor conferences in September:
- 2023 Wells Fargo Healthcare Conference: Exelixis is scheduled
to present at 11:00 a.m. ET / 8:00 a.m. PT on Friday, September 8
in Everett, MA.
- Morgan Stanley 21st Annual Global Healthcare Conference:
Exelixis is scheduled to present at 1:35 p.m. ET / 10:35 a.m. PT on
Tuesday, September 12, 2023 in New York City.
To access the webcast links, log onto www.exelixis.com and
proceed to the Event Calendar page under the Investors & News
heading. Please connect to the company’s website at least 15
minutes prior to the presentations to ensure adequate time for any
software download that may be required to listen to the webcasts.
Replays will also be available at the same location for at least 30
days.
About Exelixis
Exelixis is a globally ambitious oncology company innovating
next-generation medicines and regimens at the forefront of cancer
care. Powered by bi-coastal centers of discovery and development
excellence, we are rapidly evolving our product portfolio to target
an expanding range of tumor types and indications with our
clinically differentiated pipeline of small molecules,
antibody-drug conjugates and other biotherapeutics. This
comprehensive approach harnesses decades of robust investment in
our science and partnerships to advance our investigational
programs and extend the impact of our flagship commercial product,
CABOMETYX® (cabozantinib). Exelixis is driven by a bold scientific
pursuit to create transformational treatments that give more
patients hope for the future. For information about the company and
its mission to help cancer patients recover stronger and live
longer, visit www.exelixis.com, follow @ExelixisInc on Twitter,
like Exelixis, Inc. on Facebook and follow Exelixis on
LinkedIn.
Exelixis, the Exelixis logo and CABOMETYX are
registered U.S. trademarks.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230831134521/en/
Investors Contact: Varant Shirvanian Associate Director,
Investor Relations Exelixis, Inc. 650-837-7917
vshirvanian@exelixis.com
Media Contact: Hal Mackins For Exelixis, Inc.
415-994-0040 hal@torchcommunications.com
Exelixis (NASDAQ:EXEL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Exelixis (NASDAQ:EXEL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024